Acurx Pharmaceuticals Inc — Cash Flow (NASDAQ:ACXP) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -5.01 M-7.54 M-9.8 M-10.38 M-6.79 M -6.79 M Cash from investing activities ————— — Cash from financing activities 14.8 M3.7 M8.16 M6.62 M10.64 M 10.64 M Free cash flow -5.01 M-7.54 M-9.8 M-10.38 M-6.79 M -6.79 M

Haberler

Acurx Pharmaceuticals, Inc. (ACXP) Q4 2025 Earnings Call Transcript

Acurx Pharmaceuticals 4Ç 2025 sonuçları: Nakit artışı ve Ar-Ge ilerlemesi

Earnings call transcript: Acurx Pharmaceuticals Q4 2025 reveals cash boost and R&D progress

Acurx Pharmaceuticals hisseleri yeni rCDI denemesiyle %3 kazandı

Acurx Pharmaceuticals stock gains over 3% on new rCDI trial launch

What's Going On With Acurx Pharmaceuticals Stock Today? - Acurx Pharmaceuticals (NASDAQ:ACXP)

Why Is Acurx Pharmaceuticals Stock Falling Thursday? - Acurx Pharmaceuticals (NASDAQ:ACXP)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.61%

Why Is Acurx Pharmaceuticals Stock Up Over 105% Today? - Acurx Pharmaceuticals (NASDAQ:ACXP)

Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?

Acurx Pharmaceuticals, Inc. (ACXP) Q3 2025 Earnings Call Transcript

Acurx’ın ibezapolstat ilacı klinik deneylerde mikrobiyom koruyucu özellikler gösteriyor